Dongguan, China

Yifeng Wang

This inventor holds 1 USPTO granted patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yifeng Wang. Retrieved from https://idiyas.com/inventor/yifeng-wang-05bevlv9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yifeng Wang: Innovator in Medicinal Chemistry

Introduction

Yifeng Wang is a notable inventor based in Dongguan, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for the treatment of viral infections.

Latest Patents

Wang holds a patent for "Fused tricyclic compounds and uses thereof in medicine." This invention focuses on a fused tricyclic compound that serves as a medicament for the treatment and/or prevention of hepatitis B. The patent details a compound represented by Formula (I) or its various forms, including stereoisomers, tautomers, N-oxides, solvates, metabolites, pharmaceutically acceptable salts, or prodrugs. The invention emphasizes the therapeutic potential of these compounds in combating hepatitis B.

Career Highlights

Wang is associated with Sunshine Lake Pharma Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work has led to innovative solutions in the treatment of viral diseases, showcasing his expertise in medicinal chemistry.

Collaborations

Wang has collaborated with notable colleagues, including Jianzhou Huang and Qingyun Ren, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yifeng Wang's contributions to medicinal chemistry, particularly through his patent on fused tricyclic compounds, highlight his role as a key innovator in the fight against hepatitis B. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…